FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366337788> ?p ?o ?g. }

• W4366337788 endingPage "544" @default.
• W4366337788 startingPage "530" @default.
• W4366337788 abstract "We aimed to determine whether interferon gamma-1b prevents hospital-acquired pneumonia in mechanically ventilated patients.In a multicenter, placebo-controlled, randomized trial conducted in 11 European hospitals, we randomly assigned critically ill adults, with one or more acute organ failures, under mechanical ventilation to receive interferon gamma-1b (100 µg every 48 h from day 1 to 9) or placebo (following the same regimen). The primary outcome was a composite of hospital-acquired pneumonia or all-cause mortality on day 28. The planned sample size was 200 with interim safety analyses after enrolling 50 and 100 patients.The study was discontinued after the second safety analysis for potential harm with interferon gamma-1b, and the follow-up was completed in June 2022. Among 109 randomized patients (median age, 57 (41-66) years; 37 (33.9%) women; all included in France), 108 (99%) completed the trial. Twenty-eight days after inclusion, 26 of 55 participants (47.3%) in the interferon-gamma group and 16 of 53 (30.2%) in the placebo group had hospital-acquired pneumonia or died (adjusted hazard ratio (HR) 1.76, 95% confidence interval (CI) 0.94-3.29; P = 0.08). Serious adverse events were reported in 24 of 55 participants (43.6%) in the interferon-gamma group and 17 of 54 (31.5%) in the placebo group (P = 0.19). In an exploratory analysis, we found that hospital-acquired pneumonia developed in a subgroup of patients with decreased CCL17 response to interferon-gamma treatment.Among mechanically ventilated patients with acute organ failure, treatment with interferon gamma-1b compared with placebo did not significantly reduce the incidence of hospital-acquired pneumonia or death on day 28. Furthermore, the trial was discontinued early due to safety concerns about interferon gamma-1b treatment." @default.
• W4366337788 created "2023-04-20" @default.
• W4366337788 creator A5011336235 @default.
• W4366337788 creator A5012002626 @default.
• W4366337788 creator A5020229692 @default.
• W4366337788 creator A5024540696 @default.
• W4366337788 creator A5027208121 @default.
• W4366337788 creator A5029367903 @default.
• W4366337788 creator A5030186912 @default.
• W4366337788 creator A5030969793 @default.
• W4366337788 creator A5037174756 @default.
• W4366337788 creator A5041924838 @default.
• W4366337788 creator A5047260851 @default.
• W4366337788 creator A5048521968 @default.
• W4366337788 creator A5048900643 @default.
• W4366337788 creator A5058368377 @default.
• W4366337788 creator A5058834826 @default.
• W4366337788 creator A5059154905 @default.
• W4366337788 creator A5065960476 @default.
• W4366337788 creator A5068336126 @default.
• W4366337788 creator A5068941259 @default.
• W4366337788 creator A5070261387 @default.
• W4366337788 creator A5070435485 @default.
• W4366337788 creator A5072433064 @default.
• W4366337788 creator A5075236355 @default.
• W4366337788 creator A5078571305 @default.
• W4366337788 creator A5080750886 @default.
• W4366337788 creator A5083651369 @default.
• W4366337788 creator A5083941753 @default.
• W4366337788 creator A5086415212 @default.
• W4366337788 date "2023-04-18" @default.
• W4366337788 modified "2023-10-16" @default.
• W4366337788 title "Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial" @default.
• W4366337788 cites W1848341205 @default.
• W4366337788 cites W1972757665 @default.
• W4366337788 cites W2031039655 @default.
• W4366337788 cites W2056793603 @default.
• W4366337788 cites W2069364839 @default.
• W4366337788 cites W2074974933 @default.
• W4366337788 cites W2077906035 @default.
• W4366337788 cites W2083513831 @default.
• W4366337788 cites W2100697281 @default.
• W4366337788 cites W2103433909 @default.
• W4366337788 cites W2122919633 @default.
• W4366337788 cites W2131029325 @default.
• W4366337788 cites W2132185712 @default.
• W4366337788 cites W2136050024 @default.
• W4366337788 cites W2146826939 @default.
• W4366337788 cites W2148049376 @default.
• W4366337788 cites W2223946157 @default.
• W4366337788 cites W2296531152 @default.
• W4366337788 cites W2315957883 @default.
• W4366337788 cites W2473016454 @default.
• W4366337788 cites W2608823051 @default.
• W4366337788 cites W2610855095 @default.
• W4366337788 cites W2737501968 @default.
• W4366337788 cites W2752537900 @default.
• W4366337788 cites W2756170974 @default.
• W4366337788 cites W2769390234 @default.
• W4366337788 cites W2774868879 @default.
• W4366337788 cites W2801037449 @default.
• W4366337788 cites W2901252006 @default.
• W4366337788 cites W2948054035 @default.
• W4366337788 cites W2950985821 @default.
• W4366337788 cites W2980930900 @default.
• W4366337788 cites W2982945168 @default.
• W4366337788 cites W2988825650 @default.
• W4366337788 cites W3088019525 @default.
• W4366337788 cites W3103789918 @default.
• W4366337788 cites W3135897909 @default.
• W4366337788 cites W3175399582 @default.
• W4366337788 cites W3195863754 @default.
• W4366337788 cites W3199054172 @default.
• W4366337788 cites W3203014088 @default.
• W4366337788 cites W4206921466 @default.
• W4366337788 cites W4223492789 @default.
• W4366337788 cites W4225253025 @default.
• W4366337788 cites W4283755983 @default.
• W4366337788 cites W4285492645 @default.
• W4366337788 cites W4293201471 @default.
• W4366337788 doi "https://doi.org/10.1007/s00134-023-07065-0" @default.
• W4366337788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37072597" @default.
• W4366337788 hasPublicationYear "2023" @default.
• W4366337788 type Work @default.
• W4366337788 citedByCount "0" @default.
• W4366337788 crossrefType "journal-article" @default.
• W4366337788 hasAuthorship W4366337788A5011336235 @default.
• W4366337788 hasAuthorship W4366337788A5012002626 @default.
• W4366337788 hasAuthorship W4366337788A5020229692 @default.
• W4366337788 hasAuthorship W4366337788A5024540696 @default.
• W4366337788 hasAuthorship W4366337788A5027208121 @default.
• W4366337788 hasAuthorship W4366337788A5029367903 @default.
• W4366337788 hasAuthorship W4366337788A5030186912 @default.
• W4366337788 hasAuthorship W4366337788A5030969793 @default.
• W4366337788 hasAuthorship W4366337788A5037174756 @default.
• W4366337788 hasAuthorship W4366337788A5041924838 @default.
• W4366337788 hasAuthorship W4366337788A5047260851 @default.
• W4366337788 hasAuthorship W4366337788A5048521968 @default.

• next